CRI analyst estimates
Carter's (CRI) analyst ratings, the average price target and its range, and every firm's latest call.
CRI analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 19, 2026 | UBS | Carter's price target lowered to $38 from $41 at UBS | $38.00 |
| Sep 8, 2026 | Capital One Financial | BMO Capital Starts Carter's (CRI) at Outperform | $40.00 |
| Sep 8, 2026 | BMO Capital | Carter's initiated with an Outperform at BMO Capital | $40.00 |
| Jun 17, 2026 | Wells Fargo | Carter's upgraded to Equal Weight from Underweight at Wells Fargo | $42.00 |
| May 11, 2026 | UBS | Carter's price target raised to $41 from $40 at UBS | $41.00 |
| Apr 29, 2026 | Wells Fargo | Carter's price target raised to $33 from $28 at Wells Fargo | $33.00 |
| Apr 9, 2026 | Goldman Sachs | Carter's upgraded to Neutral from Sell at Goldman Sachs | $38.00 |
| Feb 19, 2026 | UBS | Carter's price target raised to $40 from $33 at UBS | $40.00 |
| Jan 13, 2026 | Goldman Sachs | Carter's price target raised to $29 from $26 at Goldman Sachs | $29.00 |
| Dec 11, 2025 | Goldman Sachs | Carter's initiated with a Sell at Goldman Sachs | $26.00 |
| Oct 28, 2025 | Barclays | Carter's price target raised to $26 from $23 at Barclays | $26.00 |
| Oct 28, 2025 | Wells Fargo | Carter's price target raised to $25 from $22 at Wells Fargo | $25.00 |
| Oct 28, 2025 | UBS | Carter's price target raised to $33 from $26 at UBS | $33.00 |
| Oct 14, 2025 | Barclays | Carter's price target raised to $23 from $22 at Barclays | $23.00 |
| Apr 28, 2025 | Barclays | Carter's initiated with an Underweight at Barclays | $25.00 |
- 7 firms rate CRI: 2 buy, 3 hold, 2 sell.
- The average price target is $40.00 from 4 analysts, from $38.00 to $42.00.
Updated 2026-11-02 23:10 UTC